Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Other financing activities (2016 - 2024)

Utah Medical Products (UTMD) has 15 years of Other financing activities data on record, last reported at $1000.0 in Q4 2024.

  • For Q4 2024, Other financing activities changed N/A year-over-year to $1000.0; the TTM value through Sep 2025 reached $1000.0, down 95.0%, while the annual FY2024 figure was $21000.0, 75.0% up from the prior year.
  • Other financing activities reached $1000.0 in Q4 2024 per UTMD's latest filing, down from $11000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $28000.0 in Q4 2021 and bottomed at $1000.0 in Q4 2024.
  • Average Other financing activities over 5 years is $7083.3, with a median of $5500.0 recorded in 2021.
  • Peak YoY movement for Other financing activities: tumbled 78.57% in 2022, then surged 350.0% in 2024.
  • A 5-year view of Other financing activities shows it stood at $4000.0 in 2020, then soared by 600.0% to $28000.0 in 2021, then crashed by 78.57% to $6000.0 in 2022, then tumbled by 50.0% to $3000.0 in 2023, then tumbled by 66.67% to $1000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Other financing activities were $1000.0 in Q4 2024, $11000.0 in Q2 2024, and $9000.0 in Q1 2024.